Given that unregulated proliferation is the hallmark of neoplasia, TK1 is a valuable serum marker for breast cancer, non-Hodgkin’s lymphoma, plasmacytoma, and lung cancer46. Here, TK1 is linked to non-Hodgkin lymphoma.